Please Wait
Applying Filters...

Approved Marketing Authorisations (MA) containing Lenvatinib Mesylate in Europe. Original Data : EMA Website

Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Eisai Limited,

02 2Olon Spa

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

lenvatinibmesilat

Brand Name : LENVIMA

Dosage Form : HARD CAPSULES

Dosage Strength : 4 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

02

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

lenvatinibmesilat

Brand Name : LENVIMA

Dosage Form : HARD CAPSULES

Dosage Strength : 10 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

03

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

LENVATINIB MESYLATE

Brand Name :

Dosage Form : Capsule

Dosage Strength : 4MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Available Dossier- US-EU-RoW

Registration Country : Italy

blank

04

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

LENVATINIB MESYLATE

Brand Name :

Dosage Form : Capsule

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank